■慢性阻塞性肺疾病(COPD)患者的生活质量(QOL)越来越受到关注。然而,面对成千上万的相关临床文献,研究人员和机构越来越难以识别有影响力的研究。文献计量学可以帮助研究者快速、有条不紊地分析临床研究的影响和热点趋势,加强团队合作,解决相关挑战。因此,我们使用文献计量学来分析和可视化过去31年COPD患者的生活质量数据,以了解主要作者,研究领域,和未来趋势。
■我们在WebofScienceCoreCollection中搜索了自数据库建立以来发表的文献。使用的主要术语是“慢性阻塞性肺疾病”,“生活质量”及其不同的组合。选择文章并以纯文本格式导出,以及引用信息。使用R包“bibliometrix”进行文献计量分析和数据可视化,并结合出版物数量等统计指标,核心作者的引文和产出,作者合作,主要期刊,主要研究国家和合作,和关键研究主题。
■文献计量分析包括9,219篇文章。文档类型无限制。所有出版物都在1992年至2022年之间出版,在过去十年中,发表的文章数量每年都在不断增加。周期性波动。《欧洲呼吸杂志》和《国际慢性阻塞性肺疾病杂志》成为该领域中最常被引用的期刊。在这一领域做出贡献的主要作者包括WedzichaJA,琼斯PW,辛格D,荷兰AE,和WoutersEFM。美国和英国展出了大量出版物,高引用率,以及相关领域相对密集的国际合作,其次是中国,西班牙,加拿大,和澳大利亚在这些指标中。值得注意的是,这个领域的突出主题包括肺气肿,肺康复,呼吸困难,急性加重,生活状态,和死亡率,在其他人中。未来在这一领域的研究将集中在微生物,颗粒物,家庭康复,还有太极.
■这项文献计量分析突出了QOL研究在COPD领域的重要性,这可以通知临床医生,研究人员,和政策制定者优先考虑未来调查的领域,以便制定全面的,以患者为中心的策略。同时,建议研究人员应该更多地关注核心作者,加强国际合作和团队交流,积极探索太极拳、家庭康复等特色临床特色治疗措施,开展中西医结合和自我管理的临床研究,更多地关注QOL,患者的心理健康和经济和社会负担,并最终提高患有慢性呼吸系统疾病的人的福祉。
UNASSIGNED: The quality of life (QOL) of patients with chronic obstructive pulmonary disease (COPD) is garnering increasing attention. However, faced with thousands of relevant clinical literature, it is becoming increasingly difficult for researchers and institutions to identify impactful research. Bibliometrics can help researchers quickly and methodically analyze the impact and hot trends of clinical research, strengthen teamwork, and solve related challenges. Therefore, we used bibliometrics to analyze and visualize data on the QOL of patients with COPD over the past 31 years to understand the key authors, research areas, and future trends.
UNASSIGNED: We searched the Web of Science Core Collection for literature published since the establishment of the database. The main subject terms used were \"chronic obstructive pulmonary disease\", \"quality of life\" and their different combinations. Articles were selected and exported in plain text format along with citation information. Bibliometric analysis and data visualization were performed using the R package \"bibliometrix\" and by incorporating statistical indicators such as the number of publications, citations and outputs of core authors, author collaborations, major journals, major research countries and collaborations, and key research themes.
UNASSIGNED: The bibliometric analysis included 9,219 articles. Document type is unlimited. All publications were published between 1992 and 2022, and the number of published articles increased consistently each year over the past decade, with periodic fluctuations. The European Respiratory Journal and the International Journal of Chronic Obstructive Pulmonary Disease emerged as the most frequently cited journals within this domain. Key authors contributing to this field include Wedzicha JA, Jones PW, Singh D, Holland AE, and Wouters EFM. The United States and the United Kingdom exhibited a high volume of publications, high citation rates, and relatively intense international collaboration in related areas, followed by
China, Spain, Canada, and Australia in these metrics. Notably, prominent topics within this field included emphysema, pulmonary rehabilitation, dyspnea, acute exacerbation, living status, and mortality, among others. Future research in this field will focus on microorganisms, particulate matter, family rehabilitation, and Tai Chi.
UNASSIGNED: This bibliometric analysis highlights the growing importance of QOL research in the field of COPD, which can inform clinicians, researchers, and policymakers to prioritize areas for future investigation in order to develop comprehensive, patient-centered strategies. At the same time, it is suggested that researchers should pay more attention to the core authors, strengthen international collaboration and team exchanges, actively explore characteristic clinical featured treatment measures such as Tai Chi and family rehabilitation, carry out clinical research on the integration of traditional Chinese and Western medicine and self-management, focus more on the QOL, mental health and economic and social burden of patients, and ultimately enhance the well-being of individuals with chronic respiratory diseases.